Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies
Polachek A, Gladman DD, Su J, Urowitz MB. Defining low disease activity in systemic lupus erythematosus. Arthritis Care & Res 2017;69:997-1003.
Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in SLE. J Rheumatol 2000;27:377-379.
The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus
https://pubmed.ncbi.nlm.nih.gov/15468356/Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients
https://pubmed.ncbi.nlm.nih.gov/30895904/Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
https://pubmed.ncbi.nlm.nih.gov/33091256/